New Delhi [India], March 29 : Delhi recorded 300 fresh Covid-19 cases and two deaths on Wednesday, marking a sharp uptick in infections over the last 24 hours.
According to a bulletin issued by the Delhi Health department, the capital registered two deaths from Covid over the last 24 hours.
The national capital currently has 806 active Covid cases, with the infection rate at 13.89 per cent, the bulletin stated.
Further, according to the bulletin, as many as 2,160 swab samples were tested over the last 24 hours, of which 300 tested positive for Covid-19.
Further, according to the release, a total of 4,07,85,433 Covid tests have been conducted so far.
It stated further that a total of 163 Covid patients recovered from the virus in the last 24 hours, taking the total number of recoveries to 19,82,029.
Earlier, on Tuesday, the national capital recorded 214 new Covid infections. The total number of active cases was recorded at 671 while the positivity rate jumped to 11.88 per cent.
According to a bulletin issued by the Health department on Tuesday, 81 Covid patients recovered from the virus in the city, taking the total number of recoveries to 19,81,866.
India's active caseload currently stands at 11,903 with a rate of 0.03 per cent per day and with a recovery rate currently standing at 98.78 per cent.
The Ministry of Health and Family Welfare has issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country.
"Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease," revised guidelines said.
As per the revised Covid-19 guidelines, maintain "Physical distancing, indoor mask use, hand hygiene, Symptomatic management (hydration, antipyretics, antitussive) Monitor temperature and oxygen saturation (by applying a SpO probe to fingers) Stay in contact with the treating physician.
"Seek immediate medical attention if difficulty breathing, High-grade fever/ severe cough, particularly if lasting for more than 5 days. A low threshold is to be kept for those with any of the high-risk features," guidelines discussed and prepared in January said.
Additionally, in moderate or severe diseases at high risk of progression, the guidelines recommend, "Consider Remdesivir for up to 5 days (200 mg IV on day 1 followed by 100 mg IV OD for the next 4 days)".
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor